Key result
In STEMI patients undergoing primary PCI, elevated HbA1c (≥6.5%) was not significantly associated with 1-year postdischarge mortality in multivariable analysis.
Why the study?
Does increased HbA1c (≥6.5%) predict 1-year mortality in STEMI patients undergoing primary PCI?
Population
1205 consecutive patients with ST Elevation Myocardial Infarction submitted to primary percutaneous coronary…
Comparison
HbA1c ≥6.5% vs HbA1c <6.5% without previously known diabetes
Design
Cohort
Follow-up
1 year
Authors
Loading...
HbA1c ≥6.5% was associated with higher 1-year mortality after STEMI PCI; leaves open whether targeting it improves prognosis.
Cohort (n=1,205)
No
Does increased HbA1c (≥6.5%) predict 1-year mortality in STEMI patients undergoing primary PCI?
In STEMI patients undergoing primary PCI, elevated HbA1c levels (≥6.5%) were not independently associated with 1-year mortality after multivariable adjustment.
Lazzeri et al. (2014) conducted a cohort in ST Elevation Myocardial Infarction (STEMI) (n=1,205). Increased HbA1c (≥6.5%) vs. HbA1c <6.5% without previously known diabetes was evaluated on 1-year postdischarge mortality. In STEMI patients undergoing primary PCI, elevated HbA1c (≥6.5%) was not significantly associated with 1-year postdischarge mortality in multivariable analysis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: